MENU
IXJ
ETF ticker: NYSE ARCA
PRICE
CHANGE
NET ASSETS

IXJ stock forecast, quote, news & analysis

The investment seeks to track the S&P Global 1200 Health Care (Sector) Capped IndexTM... Show more

Category: #Health
IXJ
Daily Signal:
Gain/Loss:
A.I.Advisor
published price charts
Interact to see
Advertisement
A.I.Advisor
a Summary for IXJ with price predictions
Jun 22, 2026

IXJ sees MACD Histogram crosses below signal line

IXJ saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on June 18, 2026. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 47 instances where the indicator turned negative. In of the 47 cases the stock moved lower in the days that followed. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on June 18, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on IXJ as a result. In of 91 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where IXJ declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

IXJ broke above its upper Bollinger Band on May 21, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.

IXJ moved above its 50-day moving average on June 04, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for IXJ crossed bullishly above the 50-day moving average on May 26, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 13 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where IXJ advanced for three days, in of 322 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 258 cases where IXJ Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Eli Lilly & Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), ABBVIE (NYSE:ABBV), Unitedhealth Group (NYSE:UNH), Merck & Co (NYSE:MRK), AstraZeneca PLC (NYSE:AZN), Amgen (NASDAQ:AMGN), Gilead Sciences (NASDAQ:GILD), Abbott Laboratories (NYSE:ABT), Pfizer (NYSE:PFE).

Industry description

The investment seeks to track the S&P Global 1200 Health Care (Sector) Capped IndexTM. The fund invests at least 80% of its assets in the component securities of its underlying index and in investments that have economic characteristics that are substantially identical to the component securities of its underlying index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents. The index measures the performance of companies that S&P Dow Jones Indices LLC, a subsidiary of S&P Global, Inc., deems to be a part of the healthcare sector of the economy and that SPDJI believes are important to global markets.

Market Cap

The average market capitalization across the iShares Global Healthcare ETF ETF is 86.82B. The market cap for tickers in the group ranges from 64.65K to 982.77B. LLY holds the highest valuation in this group at 982.77B. The lowest valued company is BAYN at 64.65K.

High and low price notable news

The average weekly price growth across all stocks in the iShares Global Healthcare ETF ETF was 11%. For the same ETF, the average monthly price growth was 31%, and the average quarterly price growth was 94%. MRNA experienced the highest price growth at 14%, while DXCM experienced the biggest fall at -7%.

Volume

The average weekly volume growth across all stocks in the iShares Global Healthcare ETF ETF was 6%. For the same stocks of the ETF, the average monthly volume growth was 23% and the average quarterly volume growth was 200%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 39
P/E Growth Rating: 48
Price Growth Rating: 46
SMR Rating: 57
Profit Risk Rating: 75
Seasonality Score: 31 (-100 ... +100)
View a ticker or compare two or three
IXJ
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Category Health

Profile
Details
Category
Health
Address
iShares Trust400 Howard StreetSan Francisco
Phone
415-670-2000
Web
www.ishares.com
IXJ sees MACD Histogram crosses below signal line